AI Financial Corp (AIFC) is the 268th largest of 300 Payment Processing companies by market capitalisation, at 78.20 Mn, behind Medicinova Inc at 79.25 Mn. The table below compares all 300 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | XYZ | Block, Inc. | primary | T-54 | Fintech | TG-09 | 49.66 Bn | 0.00 Bn | 1.98 | 43.23 Bn |
| 2 | PYPL | PayPal Holdings, Inc. | primary | T-54 | Fintech | TG-09 | 48.03 Bn | 0.00 Bn | 1.41 | 36.77 Bn |
| 3 | FISV | Fiserv Inc | primary | T-54 | Fintech | TG-09 | 28.38 Bn | 0.00 Bn | 1.36 | 27.75 Bn |
| 4 | CPAY | Corpay, Inc. | primary | T-54 | Fintech | TG-09 | 27.30 Bn | 0.00 Bn | 5.44 | 20.30 Bn |
| 5 | GPN | Global Payments Inc | primary | T-54 | Fintech | TG-09 | 25.29 Bn | 0.00 Bn | 2.47 | 19.88 Bn |
| 6 | WEX | WEX Inc. | primary | T-54 | Fintech | TG-09 | 6.76 Bn | 0.00 Bn | 2.42 | 0.66 Bn |
| 7 | ACIW | Aci Worldwide, Inc. | primary | T-54 | Fintech | TG-09 | 5.38 Bn | 0.00 Bn | 2.96 | 5.22 Bn |
| 8 | PAY | Paymentus Holdings, Inc. | primary | T-54 | Fintech | TG-09 | 4.54 Bn | 0.00 Bn | 3.34 | 4.16 Bn |
| 9 | DLO | dLocal Ltd | primary | T-54 | Fintech | TG-09 | 4.51 Bn | 0.00 Bn | 3.33 | 3.63 Bn |
| 10 | SEZL | Sezzle Inc. | primary | T-54 | Fintech | TG-09 | 4.05 Bn | 0.00 Bn | 7.62 | 3.97 Bn |
| 11 | FOUR | Shift4 Payments, Inc. | primary | T-54 | Fintech | TG-09 | 3.66 Bn | 0.00 Bn | 0.77 | 3.30 Bn |
| 12 | NATL | NCR Atleos Corp | primary | T-54 | Fintech | TG-09 | 3.39 Bn | 0.00 Bn | 0.77 | 2.80 Bn |
| 13 | EEFT | Euronet Worldwide, Inc. | primary | T-54 | Fintech | TG-09 | 2.81 Bn | 0.00 Bn | 0.64 | 1.62 Bn |
| 14 | PAYO | Payoneer Global Inc. | primary | T-54 | Fintech | TG-09 | 2.42 Bn | 0.00 Bn | 2.24 | 2.07 Bn |
| 15 | FLYW | Flywire Corp | primary | T-54 | Fintech | TG-09 | 2.28 Bn | 0.00 Bn | 3.20 | 1.99 Bn |
| 16 | NYAX | Nayax Ltd. | primary | T-54 | Fintech | TG-09 | 1.88 Bn | 0.00 Bn | 4.14 | 1.57 Bn |
| 17 | EVTC | EVERTEC, Inc. | primary | T-54 | Fintech | TG-09 | 1.86 Bn | 0.00 Bn | 1.87 | 1.60 Bn |
| 18 | MQ | Marqeta, Inc. | primary | T-54 | Fintech | TG-09 | 1.75 Bn | 0.00 Bn | 2.58 | 1.05 Bn |
| 19 | DLX | Deluxe Corp | primary | T-54 | Fintech | TG-09 | 1.10 Bn | 0.00 Bn | 0.52 | 1.07 Bn |
| 20 | PAYS | Paysign, Inc. | primary | T-54 | Fintech | TG-09 | 0.72 Bn | 0.00 Bn | 7.13 | 0.72 Bn |
| 21 | CASS | Cass Information Systems Inc | primary | T-54 | Fintech | TG-09 | 0.71 Bn | 0.00 Bn | 3.58 | 0.30 Bn |
| 22 | OWLS | Obook Holdings Inc. | primary | T-54 | Fintech | TG-09 | 0.46 Bn | 0.00 Bn | 63.54 | 0.44 Bn |
| 23 | PRTH | Priority Technology Holdings, Inc. | primary | T-54 | Fintech | TG-09 | 0.45 Bn | — | — | 0.37 Bn |
| 24 | PSFE | Paysafe Ltd | primary | T-54 | Fintech | TG-09 | 0.39 Bn | 0.00 Bn | 0.22 | 0.16 Bn |
| 25 | RPAY | Repay Holdings Corp | primary | T-54 | Fintech | TG-09 | 0.32 Bn | — | — | 0.17 Bn |
| 26 | BCRD | BlueOne Technologies, Inc. | primary | T-54 | Fintech | TG-09 | 0.09 Bn | 0.00 Bn | 358.31 | 0.10 Bn |
| 27 | RTB | RTB Digital, Inc. | primary | T-54 | Fintech | TG-09 | 0.09 Bn | 0.00 Bn | 10.33 | 0.09 Bn |
| 28 | AIFC | AI Financial Corp | primary | T-54 | Fintech | TG-09 | 0.08 Bn | 0.00 Bn | 3.90 | 0.07 Bn |
| 29 | RPMT | Rego Payment Architectures, Inc. | primary | T-54 | Fintech | TG-09 | 0.08 Bn | 0.00 Bn | 1,737.46 | 0.08 Bn |
| 30 | PSQH | PSQ Holdings, Inc. | primary | T-54 | Fintech | TG-09 | 0.02 Bn | 0.00 Bn | 0.72 | 0.01 Bn |
| 31 | ASFH | Asiafin Holdings Corp. | primary | T-54 | Fintech | TG-09 | 0.01 Bn | 0.00 Bn | 1.82 | 0.01 Bn |
| 32 | HMMR | Hammer Technology Holdings Corp. | primary | T-54 | Fintech | TG-09 | 0.01 Bn | 0.00 Bn | — | 0.01 Bn |
| 33 | OLB | Olb Group, Inc. | primary | T-54 | Fintech | TG-09 | 0.00 Bn | 0.00 Bn | 0.53 | 0.00 Bn |
| 34 | SUIC | SUIC Worldwide Holdings Ltd. | primary | T-54 | Fintech | TG-09 | 0.00 Bn | 0.00 Bn | 170.83 | 0.00 Bn |
| 35 | KCRD | Kindcard, Inc. | primary | T-54 | Fintech | TG-09 | 0.00 Bn | 0.00 Bn | 8.77 | 0.00 Bn |
| 36 | AAPL | Apple Inc. | secondary | T-08 | Computer Hardware | TG-02 | 4,707.18 Bn | 0.00 Bn | 10.08 | 4,644.78 Bn |
| 37 | JNJ | Johnson & Johnson | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 663.00 Bn | 0.00 Bn | 6.77 | 642.24 Bn |
| 38 | MA | Mastercard Inc | secondary | F-25 | Payments | FG-07 | 512.65 Bn | 0.00 Bn | 14.61 | 499.17 Bn |
| 39 | ABBV | AbbVie Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 452.66 Bn | 0.00 Bn | 7.03 | 446.09 Bn |
| 40 | MRK | Merck & Co., Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 371.61 Bn | 0.00 Bn | 5.58 | 364.47 Bn |
| 41 | NVS | Novartis Ag | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 309.79 Bn | 0.00 Bn | 4.51 | 302.10 Bn |
| 42 | AXP | American Express Co | secondary | F-02 | Banking | FG-01 | 222.04 Bn | 0.00 Bn | 2.92 | 172.73 Bn |
| 43 | SHOP | Shopify Inc. | secondary | T-52 | Internet Platforms | TG-08 | 189.24 Bn | 0.00 Bn | 14.26 | 184.30 Bn |
| 44 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 187.36 Bn | 0.00 Bn | 6.15 | 184.18 Bn |
| 45 | PFE | Pfizer Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 162.45 Bn | 0.00 Bn | 2.55 | 150.75 Bn |
| 46 | BKNG | Booking Holdings Inc. | secondary | T-51 | Internet Platforms | TG-08 | 148.68 Bn | 0.00 Bn | 5.26 | 131.46 Bn |
| 47 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 138.87 Bn | 0.00 Bn | 11.03 | 131.01 Bn |
| 48 | MELI | Mercadolibre Inc | secondary | T-51 | Internet Platforms | TG-08 | 100.83 Bn | 0.00 Bn | 2.87 | 85.64 Bn |
| 49 | INTU | Intuit Inc. | secondary | T-18 | Business Applications | TG-03 | 91.56 Bn | 0.00 Bn | 4.38 | 84.78 Bn |
| 50 | NU | Nu Holdings Ltd. | secondary | F-02 | Banking | FG-01 | 74.64 Bn | 0.00 Bn | 3.86 | 60.96 Bn |
| 51 | SE | Sea Ltd | secondary | T-51 | Internet Platforms | TG-08 | 67.52 Bn | 0.00 Bn | 2.54 | 58.42 Bn |
| 52 | SNY | Sanofi | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 53.81 Bn | 0.00 Bn | 1.00 | 46.43 Bn |
| 53 | COIN | Coinbase Global, Inc. | secondary | T-58 | Fintech | TG-09 | 48.60 Bn | 0.00 Bn | 7.74 | 39.81 Bn |
| 54 | EBAY | Ebay Inc | secondary | T-51 | Internet Platforms | TG-08 | 46.23 Bn | 0.00 Bn | 3.85 | 42.92 Bn |
| 55 | RVMD | Revolution Medicines, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 44.07 Bn | 0.00 Bn | — | 44.07 Bn |
| 56 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.49 Bn | 0.00 Bn | 2.45 | 38.83 Bn |
| 57 | ONC | BeOne Medicines Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 39.99 Bn | 0.00 Bn | 6.52 | 34.89 Bn |
| 58 | ALC | Alcon Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 34.90 Bn | 0.00 Bn | 3.24 | 33.44 Bn |
| 59 | GEHC | GE HealthCare Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 31.13 Bn | 0.00 Bn | 1.46 | 29.02 Bn |
| 60 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 27.41 Bn | 0.00 Bn | 24.09 | 26.25 Bn |
| 61 | CPNG | Coupang, Inc. | secondary | D-32 | Retail | DG-10 | 27.40 Bn | 0.00 Bn | 0.77 | 21.29 Bn |
| 62 | INCY | Incyte Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 25.64 Bn | 0.00 Bn | 4.41 | 21.11 Bn |
| 63 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 25.22 Bn | 0.00 Bn | 2,309.22 | 25.22 Bn |
| 64 | CRCL | Circle Internet Group, Inc. | secondary | F-22 | Capital Markets | FG-05 | 25.16 Bn | 0.00 Bn | 8.66 | 23.43 Bn |
| 65 | AFRM | Affirm Holdings, Inc. | secondary | F-04 | Lending and Credit | FG-02 | 24.32 Bn | 0.00 Bn | 5.71 | 22.69 Bn |
| 66 | SOFI | SoFi Technologies, Inc. | secondary | F-02 | Banking | FG-01 | 23.52 Bn | 0.00 Bn | 5.46 | 20.40 Bn |
| 67 | FIS | Fidelity National Information Services, Inc. | secondary | T-19 | Business Applications | TG-03 | 21.60 Bn | 0.00 Bn | 1.77 | 20.85 Bn |
| 68 | UTHR | UNITED THERAPEUTICS Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 20.84 Bn | 0.00 Bn | 6.61 | 18.18 Bn |
| 69 | KSPI | Joint Stock Co Kaspi.kz | secondary | F-02 | Banking | FG-01 | 20.65 Bn | 0.00 Bn | 0.00 | -977.96 Bn |
| 70 | VTRS | Viatris Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.74 Bn | 0.00 Bn | 1.34 | 18.85 Bn |
| 71 | TOST | Toast, Inc. | secondary | T-31 | Vertical Software | TG-05 | 19.56 Bn | 0.00 Bn | 2.88 | 17.85 Bn |
| 72 | NBIX | Neurocrine Biosciences Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.71 Bn | 0.00 Bn | 4.66 | 15.32 Bn |
| 73 | JAZZ | Jazz Pharmaceuticals plc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.63 Bn | 0.00 Bn | 3.40 | 14.01 Bn |
| 74 | TYL | Tyler Technologies Inc | secondary | T-19 | Business Applications | TG-03 | 15.29 Bn | 0.00 Bn | 6.29 | 14.32 Bn |
| 75 | EXEL | Exelixis, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.82 Bn | 0.00 Bn | 6.08 | 13.98 Bn |
| 76 | BWXT | BWX Technologies, Inc. | secondary | I-39 | Clean Energy Equipment | IG-10 | 14.46 Bn | 0.00 Bn | 4.12 | 13.86 Bn |
| 77 | GRAB | Grab Holdings Ltd | secondary | T-53 | Internet Platforms | TG-08 | 14.12 Bn | 0.00 Bn | 2.65 | 9.96 Bn |
| 78 | GDDY | GoDaddy Inc. | secondary | T-46 | Cloud Computing | TG-07 | 13.34 Bn | 0.00 Bn | 2.61 | 12.15 Bn |
| 79 | WSE | Wise Group plc | secondary | F-26 | Payments | FG-07 | 12.97 Bn | 0.00 Bn | 5.40 | 12.97 Bn |
| 80 | CHYM | Chime Financial, Inc. | secondary | T-57 | Fintech | TG-09 | 12.75 Bn | 0.00 Bn | 5.19 | 11.69 Bn |
| 81 | JKHY | Jack Henry & Associates Inc | secondary | T-57 | Fintech | TG-09 | 11.92 Bn | 0.00 Bn | 4.69 | 11.91 Bn |
| 82 | CORT | Corcept Therapeutics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.79 Bn | 0.00 Bn | 14.20 | 11.49 Bn |
| 83 | KYMR | Kymera Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.55 Bn | 0.00 Bn | 109.96 | 10.85 Bn |
| 84 | AXSM | Axsome Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.71 Bn | 0.00 Bn | 13.79 | 10.39 Bn |
| 85 | PAYP | PayPay Corp | secondary | F-02 | Banking | FG-01 | 10.69 Bn | 0.00 Bn | 6.69 | 10.69 Bn |
| 86 | GKOS | GLAUKOS Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.49 Bn | 0.00 Bn | 17.12 | 10.38 Bn |
| 87 | GPCR | Structure Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.28 Bn | 0.00 Bn | — | 10.28 Bn |
| 88 | PRAX | Praxis Precision Medicines, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.24 Bn | 0.00 Bn | — | 9.48 Bn |
| 89 | NUVL | Nuvalent, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.75 Bn | 0.00 Bn | — | 9.75 Bn |
| 90 | CYTK | Cytokinetics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.59 Bn | 0.00 Bn | 141.69 | 8.42 Bn |
| 91 | CRNX | Crinetics Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.99 Bn | 0.00 Bn | 213.22 | 8.99 Bn |
| 92 | PCOR | Procore Technologies, Inc. | secondary | T-30 | Vertical Software | TG-05 | 8.78 Bn | 0.00 Bn | 6.18 | 8.13 Bn |
| 93 | TTAN | ServiceTitan, Inc. | secondary | T-30 | Vertical Software | TG-05 | 8.42 Bn | 0.00 Bn | 8.31 | 8.00 Bn |
| 94 | HQY | Healthequity, Inc. | secondary | F-21 | Capital Markets | FG-05 | 7.99 Bn | 0.00 Bn | 5.87 | 7.73 Bn |
| 95 | ALKS | Alkermes plc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.76 Bn | 0.00 Bn | 4.65 | 7.11 Bn |
| 96 | APPF | Appfolio Inc | secondary | T-29 | Vertical Software | TG-05 | 7.63 Bn | 0.00 Bn | 7.33 | 7.41 Bn |
| 97 | NAVN | Navan, Inc. | secondary | T-18 | Business Applications | TG-03 | 7.01 Bn | 0.00 Bn | 9.34 | 6.33 Bn |
| 98 | BLRX | BioLineRx Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.46 Bn | 0.00 Bn | 4,640.10 | 6.46 Bn |
| 99 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.46 Bn | 0.00 Bn | 1.21 | 6.08 Bn |
| 100 | BLTE | Belite Bio, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.25 Bn | 0.00 Bn | — | 6.25 Bn |
| 101 | TVTX | Travere Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.14 Bn | 0.00 Bn | 10.37 | 6.14 Bn |
| 102 | LQDA | Liquidia Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.11 Bn | 0.00 Bn | 13.55 | 5.83 Bn |
| 103 | AMRN | Amarin Corp Plc\Uk | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.67 Bn | 0.00 Bn | 30.46 | 5.36 Bn |
| 104 | AMRX | Amneal Pharmaceuticals, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.56 Bn | 0.00 Bn | 1.78 | 5.43 Bn |
| 105 | KLAR | Klarna Group plc | secondary | F-02 | Banking | FG-01 | 5.32 Bn | 1.07 Bn | 10.04 | 2.51 Bn |
| 106 | GLXY | Galaxy Digital Inc. | secondary | F-22 | Capital Markets | FG-05 | 5.04 Bn | 0.00 Bn | 0.09 | 3.49 Bn |
| 107 | ERAS | Erasca, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.04 Bn | 0.00 Bn | — | 5.04 Bn |
| 108 | DAVE | Dave Inc./DE | secondary | T-57 | Fintech | TG-09 | 4.99 Bn | 0.00 Bn | 7.75 | 4.73 Bn |
| 109 | BILL | BILL Holdings, Inc. | secondary | T-18 | Business Applications | TG-03 | 4.91 Bn | 0.00 Bn | 2.97 | 2.98 Bn |
| 110 | WAY | Waystar Holding Corp. | secondary | T-27 | Vertical Software | TG-05 | 4.83 Bn | 0.00 Bn | 4.01 | 4.64 Bn |
| 111 | ACAD | Acadia Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.82 Bn | 0.00 Bn | 4.23 | 3.86 Bn |
| 112 | VNT | Vontier Corp | secondary | I-08 | Machinery | IG-02 | 4.64 Bn | 0.00 Bn | 1.51 | 4.37 Bn |
| 113 | EWTX | Edgewise Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.60 Bn | 0.00 Bn | — | 4.60 Bn |
| 114 | NNI | Nelnet Inc | secondary | F-01 | Banking | FG-01 | 4.59 Bn | 0.00 Bn | 8.31 | 4.41 Bn |
| 115 | BLSH | Bullish | secondary | T-58 | Fintech | TG-09 | 4.55 Bn | 0.00 Bn | 0.02 | 4.45 Bn |
| 116 | VEON | VEON Ltd. | secondary | C-01 | Telecommunications | CG-01 | 4.54 Bn | 0.00 Bn | 0.80 | 1.85 Bn |
| 117 | DFTX | Definium Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.26 Bn | 0.00 Bn | — | 4.26 Bn |
| 118 | WIX | Wix.com Ltd. | secondary | T-46 | Cloud Computing | TG-07 | 4.23 Bn | 0.00 Bn | — | 3.63 Bn |
| 119 | CCC | CCC Intelligent Solutions Holdings Inc. | secondary | T-27 | Vertical Software | TG-05 | 4.22 Bn | 0.00 Bn | 3.79 | 4.10 Bn |
| 120 | DNLI | Denali Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.18 Bn | 0.00 Bn | 1,159.80 | 4.18 Bn |
| 121 | INDV | Indivior Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.18 Bn | 0.00 Bn | 3.13 | 3.95 Bn |
| 122 | MANE | Veradermics, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.99 Bn | 0.00 Bn | — | 3.99 Bn |
| 123 | ELVN | Enliven Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.94 Bn | 0.00 Bn | — | 3.94 Bn |
| 124 | CPRX | CATALYST PHARMACEUTICALS, INC. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.85 Bn | 0.00 Bn | 6.45 | 3.09 Bn |
| 125 | TARS | Tarsus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.76 Bn | 0.00 Bn | 6.21 | 3.31 Bn |
| 126 | RCUS | Arcus Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.73 Bn | 0.00 Bn | 31.87 | 3.03 Bn |
| 127 | OGN | Organon & Co. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.62 Bn | 0.00 Bn | 0.59 | 2.49 Bn |
| 128 | AGYS | Agilysys Inc | secondary | T-31 | Vertical Software | TG-05 | 3.17 Bn | 0.00 Bn | 9.59 | 3.04 Bn |
| 129 | NAMS | NewAmsterdam Pharma Co N.V. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.13 Bn | 0.00 Bn | 439.49 | 3.13 Bn |
| 130 | IMNM | Immunome Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.05 Bn | 0.00 Bn | 593.06 | 2.53 Bn |
| 131 | ZLAB | Zai Lab Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.94 Bn | 0.00 Bn | 6.53 | 2.23 Bn |
| 132 | NRIX | Nurix Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.87 Bn | 0.00 Bn | 78.10 | 2.43 Bn |
| 133 | STNE | StoneCo Ltd. | secondary | F-04 | Lending and Credit | FG-02 | 2.72 Bn | 0.00 Bn | 0.99 | 2.72 Bn |
| 134 | TRVI | Trevi Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.69 Bn | 0.00 Bn | — | 2.69 Bn |
| 135 | TAK | Takeda Pharmaceutical Co Ltd | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.64 Bn | 0.00 Bn | 0.06 | -3.15 Bn |
| 136 | SLS | SELLAS Life Sciences Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.62 Bn | 0.00 Bn | — | 2.62 Bn |
| 137 | BUSE | First Busey Corp /Nv/ | secondary | F-01 | Banking | FG-01 | 2.59 Bn | 0.00 Bn | 34.67 | 1.91 Bn |
| 138 | CURLF | Curaleaf Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 2.55 Bn | 0.00 Bn | 1.95 | 2.46 Bn |
| 139 | SUPN | Supernus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.55 Bn | 0.00 Bn | 3.24 | 2.18 Bn |
| 140 | BCRX | Biocryst Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.54 Bn | 0.00 Bn | 4.75 | 2.19 Bn |
| 141 | STUB | StubHub Holdings, Inc. | secondary | T-51 | Internet Platforms | TG-08 | 2.48 Bn | 0.00 Bn | 1.28 | 0.79 Bn |
| 142 | BHC | Bausch Health Companies Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.46 Bn | 0.00 Bn | 0.23 | 0.62 Bn |
| 143 | HRMY | Harmony Biosciences Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.44 Bn | 0.00 Bn | 2.55 | 1.64 Bn |
| 144 | NUVB | Nuvation Bio Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.39 Bn | 0.00 Bn | 14.06 | 2.39 Bn |
| 145 | BHVN | Biohaven Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.37 Bn | 0.00 Bn | — | 2.10 Bn |
| 146 | MLYS | Mineralys Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.37 Bn | 0.00 Bn | — | 2.37 Bn |
| 147 | DBD | DIEBOLD NIXDORF, Inc | secondary | T-31 | Vertical Software | TG-05 | 2.34 Bn | 0.00 Bn | 0.61 | 2.06 Bn |
| 148 | BRSL | Brightstar Lottery PLC | secondary | T-19 | Business Applications | TG-03 | 2.25 Bn | 0.00 Bn | 0.91 | 1.69 Bn |
| 149 | PVLA | Palvella Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.24 Bn | 0.00 Bn | — | 1.92 Bn |
| 150 | FMS | Fresenius Medical Care AG | secondary | H-14 | Healthcare Providers | HG-04 | 2.20 Bn | 0.00 Bn | 0.08 | 0.37 Bn |
| 151 | BLKB | Blackbaud Inc | secondary | T-16 | Business Applications | TG-03 | 2.11 Bn | 0.00 Bn | 1.84 | 1.27 Bn |
| 152 | AUPH | Aurinia Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.10 Bn | 0.00 Bn | 6.75 | 1.66 Bn |
| 153 | ZBIO | Zenas BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.08 Bn | 0.00 Bn | 2,075.13 | 2.08 Bn |
| 154 | TFIN | Triumph Financial, Inc. | secondary | F-01 | Banking | FG-01 | 1.65 Bn | 0.00 Bn | 28.89 | 0.75 Bn |
| 155 | ETON | Eton Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.62 Bn | 0.00 Bn | 16.16 | 1.59 Bn |
| 156 | WB | WEIBO Corp | secondary | T-47 | Internet Platforms | TG-08 | 1.61 Bn | 0.00 Bn | 0.90 | -1.03 Bn |
| 157 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.59 Bn | 0.00 Bn | 2.22 | 1.30 Bn |
| 158 | AAPG | Ascentage Pharma Group International | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.57 Bn | 0.00 Bn | 20.12 | 1.29 Bn |
| 159 | INVA | Innoviva, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.56 Bn | 0.00 Bn | 3.03 | 0.98 Bn |
| 160 | ANIP | Ani Pharmaceuticals Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.51 Bn | 0.00 Bn | 1.54 | 1.15 Bn |
| 161 | LBRX | Lb Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.49 Bn | 0.00 Bn | — | 1.49 Bn |
| 162 | AVBP | ArriVent BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.48 Bn | 0.00 Bn | — | 1.48 Bn |
| 163 | XERS | Xeris Biopharma Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.47 Bn | 0.00 Bn | 4.39 | 1.35 Bn |
| 164 | LSPD | Lightspeed Commerce Inc. | secondary | T-31 | Vertical Software | TG-05 | 1.46 Bn | 0.00 Bn | 1.17 | 1.09 Bn |
| 165 | HROW | Harrow, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.43 Bn | 0.00 Bn | 5.17 | 1.34 Bn |
| 166 | OMER | Omeros Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.38 Bn | 0.00 Bn | 35.82 | 1.38 Bn |
| 167 | CRVS | Corvus Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.34 Bn | 0.00 Bn | — | 1.13 Bn |
| 168 | VYX | NCR Voyix Corp | secondary | T-31 | Vertical Software | TG-05 | 1.27 Bn | 0.00 Bn | 0.50 | 1.02 Bn |
| 169 | OPK | Opko Health, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.24 Bn | 0.00 Bn | 2.11 | 0.94 Bn |
| 170 | KURA | Kura Oncology, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.17 Bn | 0.00 Bn | 15.13 | 1.17 Bn |
| 171 | OLMA | Olema Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.13 Bn | 0.00 Bn | — | 1.13 Bn |
| 172 | PCRX | Pacira BioSciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.04 Bn | 0.00 Bn | 1.39 | 0.79 Bn |
| 173 | MNPR | Monopar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.01 Bn | 0.00 Bn | — | 0.96 Bn |
| 174 | LXRX | Lexicon Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.98 Bn | 0.00 Bn | 23.59 | 0.79 Bn |
| 175 | ESQ | Esquire Financial Holdings, Inc. | secondary | F-01 | Banking | FG-01 | 0.98 Bn | 0.00 Bn | 6.12 | 0.73 Bn |
| 176 | SGP | SpyGlass Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.97 Bn | 0.00 Bn | — | 0.97 Bn |
| 177 | DSGN | Design Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.95 Bn | 0.00 Bn | — | 0.75 Bn |
| 178 | JMIA | Jumia Technologies AG | secondary | T-51 | Internet Platforms | TG-08 | 0.90 Bn | 0.00 Bn | 4.29 | 0.85 Bn |
| 179 | IVA | Inventiva S.A. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.89 Bn | 0.00 Bn | 179.22 | 0.89 Bn |
| 180 | ACRS | Aclaris Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.88 Bn | 0.00 Bn | 106.98 | 0.88 Bn |
| 181 | VSTM | Verastem, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.81 Bn | 0.00 Bn | 9.21 | 0.67 Bn |
| 182 | PAR | Par Technology Corp | secondary | T-31 | Vertical Software | TG-05 | 0.80 Bn | 0.00 Bn | 1.62 | 0.73 Bn |
| 183 | COLL | Collegium Pharmaceutical, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.78 Bn | 0.00 Bn | 0.96 | 0.63 Bn |
| 184 | PHAT | Phathom Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.78 Bn | 0.00 Bn | 3.24 | 0.59 Bn |
| 185 | GDOT | Green Dot Corp | secondary | F-02 | Banking | FG-01 | 0.76 Bn | 0.00 Bn | 0.33 | -0.38 Bn |
| 186 | ZVRA | Zevra Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.73 Bn | 0.00 Bn | 5.39 | 0.51 Bn |
| 187 | VBNK | VersaBank | secondary | F-02 | Banking | FG-01 | 0.70 Bn | 0.00 Bn | 6.54 | 0.70 Bn |
| 188 | GYRE | Gyre Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.68 Bn | 0.00 Bn | 5.70 | 0.62 Bn |
| 189 | AQST | Aquestive Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.68 Bn | 0.00 Bn | 12.51 | 0.68 Bn |
| 190 | CRMD | CorMedix Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.67 Bn | 0.00 Bn | 1.78 | 0.41 Bn |
| 191 | PHR | Phreesia, Inc. | secondary | T-27 | Vertical Software | TG-05 | 0.66 Bn | 0.00 Bn | 1.33 | 0.58 Bn |
| 192 | OCS | Oculis Holding AG | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | 0.00 Bn | — | 0.35 Bn |
| 193 | MPLT | MapLight Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.63 Bn | 0.00 Bn | — | 0.63 Bn |
| 194 | TCGLF | TechCreate Group Ltd. | secondary | T-63 | Technology Services | TG-11 | 0.62 Bn | 0.00 Bn | 152.81 | 0.61 Bn |
| 195 | VRRM | VERRA MOBILITY Corp | secondary | T-32 | Vertical Software | TG-05 | 0.62 Bn | 0.00 Bn | 0.62 | 0.57 Bn |
| 196 | EOLS | Evolus, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.61 Bn | 0.00 Bn | 1.91 | 0.56 Bn |
| 197 | DCTH | Delcath Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.59 Bn | 0.00 Bn | 6.18 | 0.49 Bn |
| 198 | WEAV | Weave Communications, Inc. | secondary | T-27 | Vertical Software | TG-05 | 0.58 Bn | 0.00 Bn | 2.27 | 0.54 Bn |
| 199 | NVCT | Nuvectis Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.57 Bn | 0.00 Bn | — | 0.57 Bn |
| 200 | SPRY | ARS Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.56 Bn | 0.00 Bn | 4.77 | 0.41 Bn |
| 201 | OVID | Ovid Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.55 Bn | 0.00 Bn | 348.63 | 0.43 Bn |
| 202 | PRLD | Prelude Therapeutics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | 0.00 Bn | 24.04 | 0.26 Bn |
| 203 | XFOR | X4 Pharmaceuticals, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.51 Bn | 0.00 Bn | 32.37 | 0.32 Bn |
| 204 | CNTN | Canton Strategic Holdings, Inc. | secondary | T-58 | Fintech | TG-09 | 0.50 Bn | 0.00 Bn | 326.20 | 0.50 Bn |
| 205 | ANL | Adlai Nortye Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.50 Bn | 0.00 Bn | 78.36 | 0.26 Bn |
| 206 | EVMN | Evommune, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.45 Bn | 0.00 Bn | 44.84 | 0.25 Bn |
| 207 | IRD | Opus Genetics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | 0.00 Bn | 44.69 | 0.35 Bn |
| 208 | CYPH | Cypherpunk Technologies Inc. | secondary | T-58 | Fintech | TG-09 | 0.44 Bn | 0.00 Bn | — | 0.44 Bn |
| 209 | PALI | Palisade Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | 0.00 Bn | 875.12 | 0.31 Bn |
| 210 | IMXI | International Money Express, Inc. | secondary | F-26 | Payments | FG-07 | 0.43 Bn | 0.00 Bn | 0.78 | 0.28 Bn |
| 211 | IKT | Inhibikase Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.43 Bn | 0.00 Bn | — | 0.27 Bn |
| 212 | VTVT | vTv Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | 0.00 Bn | 11.24 | 0.41 Bn |
| 213 | BTQ | BTQ Technologies Corp. | secondary | T-42 | Infrastructure Software | TG-06 | 0.41 Bn | 0.00 Bn | 1,012.46 | 0.41 Bn |
| 214 | TREE | LendingTree, Inc. | secondary | T-51 | Internet Platforms | TG-08 | 0.40 Bn | 0.00 Bn | 0.31 | 0.28 Bn |
| 215 | LSAK | Lesaka Technologies Inc | secondary | F-04 | Lending and Credit | FG-02 | 0.37 Bn | 0.00 Bn | 0.53 | 0.28 Bn |
| 216 | ACHV | Achieve Life Sciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.37 Bn | — | — | 0.37 Bn |
| 217 | RZLV | Rezolve Ai Plc | secondary | T-52 | Internet Platforms | TG-08 | 0.36 Bn | 0.00 Bn | 7.66 | 0.25 Bn |
| 218 | NEWT | NewtekOne, Inc. | secondary | F-02 | Banking | FG-01 | 0.35 Bn | 0.00 Bn | 1.20 | -0.04 Bn |
| 219 | SCTH | Securetech Innovations, Inc. | secondary | T-61 | Robotics and Automation | TG-10 | 0.34 Bn | — | — | 0.34 Bn |
| 220 | VNDA | Vanda Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.33 Bn | 0.00 Bn | 1.51 | 0.16 Bn |
| 221 | IIIV | i3 Verticals, Inc. | secondary | T-19 | Business Applications | TG-03 | 0.32 Bn | 0.00 Bn | 1.48 | 0.32 Bn |
| 222 | EBS | Emergent BioSolutions Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | 0.00 Bn | 0.42 | 0.18 Bn |
| 223 | SION | Sionna Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | 0.00 Bn | — | 0.32 Bn |
| 224 | IMRX | Immuneering Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | 0.00 Bn | — | 0.32 Bn |
| 225 | SWKHL | SWK Holdings Corp | secondary | F-06 | Lending and Credit | FG-02 | 0.31 Bn | 0.00 Bn | 7.50 | 0.27 Bn |
| 226 | TTRX | Turn Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | 0.00 Bn | — | 0.30 Bn |
| 227 | FULC | Fulcrum Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | 0.00 Bn | — | 0.29 Bn |
| 228 | ZNTL | Zentalis Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | 0.00 Bn | — | 0.29 Bn |
| 229 | CNCK | Coincheck Group N.V. | secondary | T-58 | Fintech | TG-09 | 0.27 Bn | 0.00 Bn | 0.08 | 0.17 Bn |
| 230 | AKBA | Akebia Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.27 Bn | 0.00 Bn | 1.22 | 0.11 Bn |
| 231 | ASUR | Asure Software Inc | secondary | T-21 | Business Applications | TG-03 | 0.26 Bn | 0.00 Bn | 1.70 | 0.24 Bn |
| 232 | CELG-RI | Bristol Myers Squibb Co | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.25 Bn | 0.00 Bn | 0.01 | -10.82 Bn |
| 233 | SIGA | Siga Technologies Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.24 Bn | — | — | 0.08 Bn |
| 234 | BGIN | BGIN BLOCKCHAIN Ltd | secondary | T-01 | Semiconductors | TG-01 | 0.23 Bn | 0.00 Bn | 3.41 | 0.20 Bn |
| 235 | FTH | Faeth Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | 0.00 Bn | — | 0.23 Bn |
| 236 | TNXP | Tonix Pharmaceuticals Holding Corp. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | 0.00 Bn | 7.52 | 0.22 Bn |
| 237 | DERM | Journey Medical Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | 0.00 Bn | 3.20 | 0.19 Bn |
| 238 | FUFU | Bitfufu Inc. | secondary | T-59 | Fintech | TG-09 | 0.22 Bn | 0.00 Bn | 0.54 | 0.19 Bn |
| 239 | WEWA | Wewards, Inc. | secondary | T-58 | Fintech | TG-09 | 0.21 Bn | 0.00 Bn | — | 0.21 Bn |
| 240 | NERV | Minerva Neurosciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | 0.00 Bn | — | 0.21 Bn |
| 241 | ACOG | Alpha Cognition Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | 0.00 Bn | 15.36 | 0.16 Bn |
| 242 | CURR | Currenc Group Inc. | secondary | F-26 | Payments | FG-07 | 0.20 Bn | 0.00 Bn | 5.41 | 0.13 Bn |
| 243 | TONX | TON Strategy Co | secondary | T-58 | Fintech | TG-09 | 0.19 Bn | 0.00 Bn | 8.85 | 0.19 Bn |
| 244 | USBC | USBC, Inc. | secondary | T-58 | Fintech | TG-09 | 0.19 Bn | 0.00 Bn | — | 0.19 Bn |
| 245 | SLGL | Sol-Gel Technologies Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | 0.00 Bn | 106.68 | 0.14 Bn |
| 246 | MCUJF | Medicure Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | 0.00 Bn | 8.18 | 0.19 Bn |
| 247 | CRDL | Cardiol Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | 0.00 Bn | — | 0.17 Bn |
| 248 | LONA | LeonaBio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | 0.00 Bn | — | 0.14 Bn |
| 249 | LENZ | LENZ Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.18 Bn | 0.00 Bn | 8.46 | 0.18 Bn |
| 250 | UTKN | Universal Token | secondary | T-58 | Fintech | TG-09 | 0.17 Bn | 0.00 Bn | -120,805.62 | 0.17 Bn |
| 251 | MENS | Jyong Biotech Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.17 Bn | 0.00 Bn | — | 0.17 Bn |
| 252 | DFDV | DeFi Development Corp. | secondary | T-29 | Vertical Software | TG-05 | 0.16 Bn | 0.00 Bn | 3.67 | 0.15 Bn |
| 253 | TNYA | Tenaya Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | 0.00 Bn | 111.69 | 0.15 Bn |
| 254 | IFRX | InflaRx N.V. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | 0.00 Bn | 1,890.67 | -0.04 Bn |
| 255 | EXOD | Exodus Movement, Inc. | secondary | T-58 | Fintech | TG-09 | 0.14 Bn | 0.00 Bn | 1.33 | -0.21 Bn |
| 256 | BMEA | Biomea Fusion, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | 0.00 Bn | — | 0.14 Bn |
| 257 | SPRB | Spruce Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | 0.00 Bn | — | 0.14 Bn |
| 258 | DVLT | Datavault AI Inc. | secondary | T-36 | Infrastructure Software | TG-06 | 0.14 Bn | 0.00 Bn | 2.97 | 0.14 Bn |
| 259 | WTF | Waton Financial Ltd | secondary | F-19 | Capital Markets | FG-05 | 0.13 Bn | 0.00 Bn | 12.14 | 0.11 Bn |
| 260 | VANI | Vivani Medical, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | 0.00 Bn | — | 0.11 Bn |
| 261 | NTHI | Neonc Technologies Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | 0.00 Bn | — | 0.13 Bn |
| 262 | STEX | Streamex Corp. | secondary | T-58 | Fintech | TG-09 | 0.12 Bn | 0.00 Bn | 722.56 | 0.11 Bn |
| 263 | AARD | Aardvark Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.12 Bn | 0.00 Bn | — | 0.04 Bn |
| 264 | VRCA | Verrica Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | 0.00 Bn | 3.76 | 0.10 Bn |
| 265 | CPIX | Cumberland Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | 0.00 Bn | 3.25 | 0.10 Bn |
| 266 | RGC | Regencell Bioscience Holdings Ltd | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | — | — | 0.09 Bn |
| 267 | CGTX | Cognition Therapeutics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | 0.00 Bn | — | 0.09 Bn |
| 268 | FRMM | FORUM MARKETS Inc | secondary | T-58 | Fintech | TG-09 | 0.09 Bn | 0.00 Bn | 8.43 | 0.09 Bn |
| 269 | THRY | Thryv Holdings, Inc. | secondary | T-16 | Business Applications | TG-03 | 0.09 Bn | 0.00 Bn | 0.13 | 0.08 Bn |
| 270 | PYPD | PolyPid Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | 0.00 Bn | — | 0.08 Bn |
| 271 | PTHS | Pelthos Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | 0.00 Bn | 1.61 | 0.06 Bn |
| 272 | FBIO | Fortress Biotech, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | 0.00 Bn | 1.25 | -0.11 Bn |
| 273 | TENX | Tenax Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | 0.00 Bn | — | 0.09 Bn |
| 274 | ANTA | Antalpha Platform Holding Co | secondary | T-56 | Fintech | TG-09 | 0.08 Bn | 0.00 Bn | 0.00 | -0.88 Bn |
| 275 | MNOV | Medicinova Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | 0.00 Bn | 91.29 | 0.08 Bn |
| 276 | WKEY | Wisekey International Holding S.A. | secondary | T-38 | Infrastructure Software | TG-06 | 0.07 Bn | 0.00 Bn | 3.84 | 0.07 Bn |
| 277 | BLNC | Balance Labs, Inc. | secondary | F-10 | Asset and Wealth Management | FG-03 | 0.07 Bn | 0.00 Bn | 798.03 | 0.07 Bn |
| 278 | BTCS | BTCS Inc. | secondary | T-58 | Fintech | TG-09 | 0.07 Bn | 0.00 Bn | 4.14 | -0.01 Bn |
| 279 | PLRX | Pliant Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | 0.00 Bn | — | 0.07 Bn |
| 280 | PMVP | PMV Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | 0.00 Bn | — | -0.01 Bn |
| 281 | CING | Cingulate Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | 0.00 Bn | — | 0.07 Bn |
| 282 | BOLD | Boundless Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | 0.00 Bn | — | 0.06 Bn |
| 283 | VERU | Veru Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | 0.00 Bn | — | 0.04 Bn |
| 284 | GOSS | Gossamer Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | 0.00 Bn | 1.05 | 0.00 Bn |
| 285 | MFI | mF International Ltd | secondary | T-40 | Infrastructure Software | TG-06 | 0.05 Bn | — | 12.04 | 0.03 Bn |
| 286 | KPTI | Karyopharm Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | 0.00 Bn | 0.35 | 0.05 Bn |
| 287 | ANVS | Annovis Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | 0.00 Bn | — | 0.05 Bn |
| 288 | PTN | Palatin Technologies Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | 0.00 Bn | 3.82 | 0.05 Bn |
| 289 | HYPD | Hyperion Defi, Inc. | secondary | T-58 | Fintech | TG-09 | 0.05 Bn | 0.00 Bn | 33.29 | 0.04 Bn |
| 290 | CLNN | Clene Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | 0.00 Bn | 222.77 | 0.05 Bn |
| 291 | APRE | Aprea Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | 0.00 Bn | — | 0.04 Bn |
| 292 | IXHL | Incannex Healthcare Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | 0.00 Bn | — | 0.04 Bn |
| 293 | APLM | Apollomics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | 0.00 Bn | 4.72 | 0.04 Bn |
| 294 | SCLX | Scilex Holding Co | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | 0.00 Bn | 1.20 | -0.07 Bn |
| 295 | GRCE | Grace Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | 0.00 Bn | — | 0.04 Bn |
| 296 | CPHI | China Pharma Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 0.00 Bn | 8.65 | 0.03 Bn |
| 297 | FIEE | FiEE, Inc. | secondary | T-63 | Technology Services | TG-11 | 0.03 Bn | 0.00 Bn | 2.58 | 0.03 Bn |
| 298 | UG | United Guardian Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 0.00 Bn | 2.95 | 0.02 Bn |
| 299 | ACTU | Actuate Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 0.00 Bn | — | 0.03 Bn |
| 300 | BETRF | BetterLife Pharma Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 0.00 Bn | — | 0.03 Bn |